Device Firms' Acquisition Activity Poised To Increase In 2010 - Analysts
This article was originally published in The Gray Sheet
Executive SummaryMedical device acquisition activity is poised to rebound and possibly accelerate through the rest of 2010, some industry watchers say, now that capital markets are beginning to loosen up and the national health reform law is in place
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.